Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

Long-pulsed ruby laser effectively reduces hair in male-to-female transsexuals.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Hirsutism treatment should focus more on patient needs and quality of life.

Women also use 5α-reductase inhibitors, and their effects differ from men.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Facial hair is crucial for transgender men's gender identity and transition.

Managing menopause symptoms like skin changes and hair thinning involves hormone therapy, procedures, and skincare, with emotional support being important.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Finasteride effectively reduces excess hair in women with certain conditions.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

A woman's virilization symptoms were caused by her partner's use of testosterone cream, which resolved after they separated.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Ovarian hyperthecosis caused high testosterone and virilization symptoms in a 60-year-old woman, which improved after surgery.

A rare ovarian tumor caused a postmenopausal woman to develop male-like features, which improved after surgery.

New compounds may soon be tested to treat excessive hair growth in women.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Finasteride effectively treats hair loss in transgender men with few side effects.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Topical 3% minoxidil effectively and safely enhances facial hair in transgender men.